Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China · Delayed Price · Currency is CNY 6.95
-0.41 (-5.57%)
Sep 10, 2026, 2:38 PM CST
SHE:002107 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,248 | 3,602 | 2,759 | 3,504 | 3,579 | 4,271 | |
Market Cap Growth | 9.20% | 30.54% | -21.25% | -2.10% | -16.22% | -7.96% |
Enterprise Value | 3,860 | 3,227 | 2,457 | 3,170 | 3,373 | 4,108 |
Last Close Price | 7.36 | 6.00 | 4.51 | 5.43 | 5.55 | 6.39 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 35.08 | 37.63 | 75.79 | 59.62 | 33.33 | 26.14 |
PS Ratio | 5.41 | 4.41 | 3.61 | 3.85 | 3.53 | 4.53 |
PB Ratio | 6.03 | 5.00 | 3.82 | 4.20 | 4.53 | 4.60 |
P/TBV Ratio | 6.63 | 5.48 | 4.38 | 4.76 | 5.28 | 5.82 |
P/FCF Ratio | 31.92 | 28.21 | 31.47 | 27.69 | 20.05 | 23.59 |
P/OCF Ratio | 31.56 | 28.02 | 30.15 | 27.11 | 19.32 | 21.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.92 | 3.95 | 3.22 | 3.49 | 3.32 | 4.36 |
EV/EBITDA Ratio | 24.18 | 26.89 | 35.61 | 39.83 | 24.66 | 18.26 |
EV/EBIT Ratio | 30.08 | 36.08 | 66.29 | 67.36 | 33.13 | 21.40 |
EV/FCF Ratio | 29.00 | 25.28 | 28.02 | 25.05 | 18.90 | 22.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0 | 0.00 | - |
Debt / EBITDA Ratio | 0.00 | 0.01 | 0.03 | 0.00 | 0.01 | - |
Debt / FCF Ratio | 0.01 | 0.01 | 0.03 | 0.00 | 0.01 | - |
Net Debt / Equity Ratio | -0.55 | -0.55 | -0.47 | -0.48 | -0.35 | -0.35 |
Net Debt / EBITDA Ratio | -2.43 | -3.28 | -4.96 | -5.04 | -2.02 | -1.45 |
Net Debt / FCF Ratio | -2.90 | -3.08 | -3.91 | -3.17 | -1.55 | -1.80 |
Asset Turnover | 0.79 | 0.83 | 0.72 | 0.81 | 0.90 | 0.75 |
Inventory Turnover | 1.71 | 2.03 | 1.65 | 1.59 | 1.64 | 1.53 |
Quick Ratio | 1.89 | 1.95 | 1.79 | 1.81 | 1.58 | 2.21 |
Current Ratio | 2.36 | 2.35 | 2.24 | 2.34 | 2.11 | 3.05 |
Return on Equity (ROE) | 16.20% | 12.30% | 4.34% | 5.75% | 10.46% | 17.47% |
Return on Assets (ROA) | 8.04% | 5.69% | 2.17% | 2.62% | 5.63% | 9.48% |
Return on Invested Capital (ROIC) | 36.13% | 21.91% | 7.22% | 8.49% | 14.81% | 26.84% |
Return on Capital Employed (ROCE) | 17.90% | 12.10% | 5.00% | 5.50% | 12.50% | 20.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.79% | 2.66% | 1.32% | 1.68% | 3.00% | 3.82% |
FCF Yield | 3.13% | 3.54% | 3.18% | 3.61% | 4.99% | 4.24% |
Dividend Yield | 3.43% | 4.44% | - | 4.60% | - | 4.07% |
Payout Ratio | 129.45% | 72.37% | 396.40% | - | 139.75% | 94.77% |
Buyback Yield / Dilution | 7.16% | 7.20% | -3.24% | -3.98% | 3.15% | -1.13% |
Total Shareholder Return | 10.58% | 11.64% | -3.24% | 0.63% | 3.15% | 2.94% |